Coherus Oncology, Inc. Common Stock
CHRS
CHRS
111 hedge funds and large institutions have $595M invested in Coherus Oncology, Inc. Common Stock in 2018 Q4 according to their latest regulatory filings, with 25 funds opening new positions, 40 increasing their positions, 31 reducing their positions, and 23 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
111
Holders Change
+2
Holders Change %
+1.83%
% of All Funds
2.48%
Holding in Top 10
1
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-50%
% of All Funds
0.02%
New
25
Increased
40
Reduced
31
Closed
23
Calls
$531K
Puts
$833K
Net Calls
-$302K
Net Calls Change
+$513K
Top Buyers
| 1 |
RCMNY
Rubric Capital Management (New York)
New York
|
$27.6M |
| 2 |
CC
Carlson Capital
Dallas,
Texas
|
$15.6M |
| 3 |
JPMorgan Chase & Co
New York
|
$33.8M |
| 4 |
Adage Capital Partners
Boston,
Massachusetts
|
$6.34M |
| 5 |
State Street
Boston,
Massachusetts
|
$23.9M |
| Name | Holding | Trade Value |
Shares Change |
Shares Change % |
|
|---|---|---|---|---|---|
|
FRM
126
Fox Run Management
Greenwich,
Connecticut
| – | -$206K | -12,490 | Closed |
|
127
Pacer Advisors
Malvern,
Pennsylvania
| – | -$79K | -4,767 | Closed |
|
|
CI
128
Cowen Inc
New York
| – | -$41K | -2,500 | Closed |
|
|
CG
129
Cutler Group
San Francisco,
California
| – | -$29K | -1,800 | Closed |
|
|
HMS
130
Hanseatic Management Services
Albuquerque,
New Mexico
| – | -$3K | -189 | Closed |
|